反应详情

A solution of the product from Example AI ([S-(R*,R*)]-2-(2-amino-4-methyl-pentanoylamino)-3-(4-benzyloxy-phenyl)-propionic acid tert-butyl ester) (220 mg, 0.50 mmol), piperidinesulfonyl chloride (102 mg, 0.55 mmol, prepared by the method of Von Geldern, et al., J. Med. Chem., 1996;39:968-981), N,N-diisopropylethylamine (129 mg, 1.00 mmol), and DMAP (20 mg) in DMF (1 mL) is stirred at room temperature for 48 hours, diluted with ethyl acetate, and washed with water, 1N HCl, saturated NaHCO3 solution and brine, dried over anhydrous sodium sulfate, and concentrated. The remaining oily residue was purified via preparative TLC (50% EtOAc/hexane) giving a clear oil which was dissolved in 0.5 mL CHCl3, and diluted with 5 mL hexane. After 3 days at 3° C., the crystals that had formed were collected, and weighed 34 mg (12%), mp=125-126° C.

1. washwashed with water, 1N HCl, saturated NaHCO3 solution and brine
2. dry with materialdried over anhydrous sodium sulfate
3. concentrationconcentrated
4. customThe remaining oily residue was purified via preparative TLC (50% EtOAc/hexane)
5. customgiving a clear oil which
6. customthe crystals that had formed
7. customwere collected